Naoki Kanomata

14PUBLICATIONS
12CO-AUTHORS
Cellular immunologySolid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Clinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 27, 2026
Standardising Immunocytochemistry on Breast Cytology: A Formalin Post-Fixation Protocol Achieves High Concordance With Immunohistochemistry for Oestrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2.

|Aug 13, 2026
Follicular Lymphoma Arising in an Ileal Neobladder Presenting as a Large Pelvic Mass.

|May 14, 2026
Impact of BRCA1/2 pathogenic variants on ipsilateral breast tumor recurrence and prognosis following breast-conserving surgery.

|Mar 02, 2026
Undifferentiated Castration-Resistant Prostate Cancer Successfully Treated With Carboplatin and Paclitaxel.

Masayuki Sano, Masaki Shimbo, Shin Ohgita

|May 13, 2025
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol.

Takeshi Ushigusa, Nami Hirakawa, Naoki Kanomata

|Dec 27, 2024
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort study.

Takeshi Ushigusa, Nami Hirakawa, Yuka Kajiura

Pageof 3

Frequent Collaborators

4 joint publications

Takeshi Ushigusa

4 joint publications

Atsushi Yoshida

1 joint publications

Nami Hirakawa

1 joint publications

Masayuki Sano